MRN is a clinical trial support organisation that focuses on supporting drug developers, health organisations, and investigators to speed up the drug development process. The company manages clinical trials at patients’ homes for customers including pharmaceutical and biotechnology firms. It delivers clinical trials in more than 50 countries and completes over 1,600 home trial visits a month. The Milton Keynes-based firm was founded by executive chairman Graham Wylie and chief executive Stuart Redding in 2006. To date, MRN has raised a total of £6.1m in equity finance and secured £643,000 in grants. It has also expanded its international presence into the US, Spain, Germany, and Japan.